Идёт набор NCT06779747

Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology

— Наблюдательное Hypothyroidism Hyperthyroidism/Thyrotoxicosis Thyroid Nodule (Benign) Thyroid Carcinoma

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально: Состояния в реестре: Hypothyroidism, Hyperthyroidism/Thyrotoxicosis, Thyroid Nodule (Benign), Thyroid Carcinoma. Базовые параметры: от 18 лет · Все.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: Италия
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Обзор

Observational single-center prospective and retrospective, nonpharmacological, spontaneous cohort study.

Подробное описание

The study is observational single-center prospective and retrospective, nonpharmacological, spontaneous cohort study. This study will be offered to any patient with thyroid pathology (hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, and thyroid carcinoma) followed by our Center with a minimum 3-month follow-up. In the retrospective phase, patients in whom thyroid pathology was diagnosed from 01/01/1995 until the approval of this study will be enrolled, while in the prospective phase those diagnosed from the time of the approval of this study to the next 10 years will be enrolled. In both phases, each patient will be followed for a maximum duate of 20 years.

Patients participating in the study will not undergo any procedure (laboratory or instrumental examination, examination or treatment) that is beyond the scope of normal daily clinical practice. Likewise, the clinical variables that will be collected for the study are those that are commonly collected by the physician in daily clinical practice.

Первичные конечные точки

Characterization of Patient Population with Thyroid Disease (Hypothyroidism, Hyperthyroidism, Benign Nodules, Thyroid Carcinoma) [Срок оценки: through study completion, an average of 17 years]

Вторичные конечные точки (8)

Comparison of L-Thyroxine Formulations (Capsules, Soft-Gel, Liquid) in Hypothyroidism Therapy [Срок оценки: through study completion, an average of 17 years]
Comparison of L-Thyroxine + L-Thyronine Combination Therapy in Hypothyroidism [Срок оценки: through study completion, an average of 17 years]
Evaluation of Drug-Induced Dysthyroidism [Срок оценки: through study completion, an average of 17 years]
Impact of the Great Score on Radio-Metabolic Therapy Response in Basedow's Disease [Срок оценки: through study completion, an average of 17 years]
Evaluation of Efficacy and Adverse Effects of Local or Systemic Drugs in Basedow's Ophthalmopathy and Pretibial Myxedema [Срок оценки: through study completion, an average of 17 years]
Evaluation of Prognostic Impact of the McGill Score for Cytologically Indeterminate Thyroid Nodules [Срок оценки: through study completion, an average of 17 years]
Evaluation of Additional Prognostic Factors for Malignancy in Thyroid Nodules [Срок оценки: through study completion, an average of 17 years]
Efficacy and Adverse Effects of Minimally Invasive Treatments for Thyroid Nodules (Radiofrequency, Laser) [Срок оценки: through study completion, an average of 17 years]

Критерии участия

Критерии включения

Age older than 18 years at the time of diagnosis;
Patients with thyroid pathology (hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, and thyroid carcinoma) in whom the diagnosis was made in our Center or another Center from 01/01/1995 until the approval of this study (retrospective phase) or from the time of approval of this study to the next 10 years (prospective phase);
Obtaining informed consent.